N2OFF completes acquisition of cancer drug discovery firm MitoCareX

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. ENOV
8. AON
9. NIO
10. PANW

Go back to N2OFF completes acquisition of cancer drug discovery firm MitoCareX
(NASDAQ: NITO) Delayed: 1.22 --0 (-0%)
Previous Close $1.22    52 Week High $ 
Open $1.22    52 Week Low $ 
Day High $1.22    P/E N/A 
Day Low $1.22    EPS $ 
Volume 13,839       

(NASDAQ: SPRC) Delayed: 5.67 -0.96 (14.48%)
Previous Close $6.63    52 Week High $ 
Open $6.06    52 Week Low $ 
Day High $6.22    P/E N/A 
Day Low $5.50    EPS $ 
Volume 90,289